Corvus Pharmaceuticals, Inc.
ADENOSINE PATHWAY INHIBITORS FOR CANCER TREATMENT

Abstract:

Provided herein are, inter alia, methods for treating cancer in subjects expressing elevated levels of adenosine A2A receptors, and optionally further expressing elevated levels of CD73 and/or PD-L1, by administering adenosine pathway inhibitors.